Literature DB >> 26070621

Alternative Aortic Access: Translumbar, Transapical, Subclavian, Conduit, and Transvenous Access to the Aorta.

Jonathan D Steinberger1, Justin P McWilliams1, John M Moriarty2.   

Abstract

Large-caliber access to the arterial system is more frequently required in the age of thoracic endovascular aneurysm repair, endovascular aneurysm repair, and transaortic valve implantation. Frequently either anatomical or vessel size constraints preclude use of common access points such as the common femoral, radial, and brachial arteries. Alternative approaches include percutaneous access at alternate sites (subclavian, axillary, and carotid), open surgical access to the heart (left ventricular apex), open surgical access to large-caliber vessels (ascending aorta, subclavian, and axillary arteries, retroperitoneal access to the iliac artery or distal aorta), and novel percutaneous approaches (transvenous). Such approaches require additional skill sets, equipment, and, frequently, multidisciplinary teams to ensure safety and success. The techniques and approaches outlined in this article may allow expansion of endovascular treatments to greater patient populations and disease states than previously thought feasible.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  access; alternative; aorta; endovascular; transapical; transvenous

Mesh:

Year:  2015        PMID: 26070621     DOI: 10.1053/j.tvir.2015.04.007

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  2 in total

1.  Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device.

Authors:  Zisis Dimitriadis; Werner Scholtz; Stephan M Ensminger; Cornelia Piper; Thomas Bitter; Marcus Wiemer; Marios Vlachojannis; Jochen Börgermann; Lothar Faber; Dieter Horstkotte; Jan Gummert; Smita Scholtz
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

2.  Trans-Iliac Aortic Valve Replacement: Feasibility, Safety, and Medium-Term Follow-up.

Authors:  Marco Gennari; Piero Trabattoni; Mauro Pepi; Gianluca Polvani; Luca Salvi; Marco Agrifoglio
Journal:  Open J Cardiovasc Surg       Date:  2019-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.